Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

A revised GDP series with base year 2022-23 is expected by February 2026, incorporating GST and UPI data, MCA-21 records, and broader coverage of unlisted firms and financial services. In ITS 2025 ...

Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...

Try shopping for a USB-C cable and you’ll no doubt be struck by the confusing disparities in cable pricing and performance claims. These are just cables, right? Can they really be that different? At ...

You may be familiar with executive titles like chief executive officer (CEO), chief financial officer (CFO) and chief operating officer (COO). But are you acquainted with your business’s chief ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Figure 1: Magnetoresistive head for hard-disk recording. The MRAM potentially combines key advantages such as non-volatility, infinite endurance and fast random access (down to 5 ns read/write time 34 ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Gordon Scott has been an active investor and ...